Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Lopez Robles J, Carmona-Bayonas A, Jimenez-Fonseca P. Decoding risk: Caravaggio's insights into risk factors for anticoagulation in cancer-associated thrombosis. Eur J Intern Med. 2023 Jun;112:21-23. doi: 10.1016/j.ejim.2023.03.022. Epub 2023 Mar 28. No abstract available. PubMed PMID: 36990876.
AÑO: 2023; IF: 5.9
36990876
Garcia-Torralba E, Perez Ramos M, Ivars Rubio A, Navarro-Manzano E, Blaya Boluda N, de la Morena Barrio P, Garcia-Garre E, Martinez Diaz F, Chaves-Benito A, Garcia-Martinez E, Ayala de la Pena F. Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer. Cancers (Basel). 2023 May 20;15(10):2846. doi: 10.3390/cancers15102846. PubMed PMID: 37345183; PubMed Central PMCID: PMC10216816.
AÑO: 2023; IF: 4.5
37345183
Soler-Espejo E, Marco-Ayala J, Chen-Liang TH, Lopez-Poveda MJ, Teruel-Montoya R, Ortuno FJ. CD5+ follicular lymphoma rapidly transformed to high-grade B-cell lymphoma with double-hit: from BCL2 to MYC disruption. Blood Res. 2023 Mar 31;58(1):79-82. doi: 10.5045/br.2023.2023039. No abstract available. PubMed PMID: 36987619; PubMed Central PMCID: PMC10063588.
AÑO: 2023; IF: 2.2
36987619
Torrent A, Morgades M, Garcia-Calduch O, de Llano MPQ, Montesinos P, Navarro I, Hernandez-Rivas JM, Barez-Garcia A, Gonzalez-Campos J, Oiartzabal I, Valero M, Cervera M, Zudaire T, Albors-Ferreiro M, Lopez-Godino O, Gil-Cortes C, Villalon L, Saldana R, Ribera JM. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain. Eur J Haematol. 2023 Sep;111(3):485-490. doi: 10.1111/ejh.14031. Epub 2023 Jun 28. PubMed PMID: 37381686.
AÑO: 2023; IF: 2.3
37381686
Rosinol L, Oriol A, Rios R, Blanchard MJ, Jarque I, Bargay J, Hernandez MT, Cabanas V, Carrillo-Cruz E, Sureda A, Martinez-Lopez J, Krsnik I, Gonzalez ME, Casado LF, Marti JM, Encinas C, de Arriba F, Palomera L, Sampol A, Gonzalez-Montes Y, Cabezudo E, Paiva B, Puig N, Cedena MT, de la Cruz J, Mateos MV, San Miguel J, Lahuerta JJ, Blade J. Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma. Blood. 2023 Nov 2;142(18):1518-1528. doi: 10.1182/blood.2022019531. PubMed PMID: 37506339.
AÑO: 2023; IF: 21.0
37506339
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL